Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
restructuring
Biotech
Genentech's cancer restructure made 'for scientific reasons'
The recent decision to merge Genentech’s two cancer departments was made for “scientific reasons,” according to executives.
James Waldron
Sep 10, 2024 5:56am
Genentech is laying off 93 staffers in South San Francisco
Aug 28, 2024 10:40am
3 biotechs try to beat the summer heat by shedding staff
Aug 1, 2024 10:49am
VBI Vaccines files for bankruptcy, seeks asset sale
Jul 30, 2024 10:56am
CureVac gains $430M GSK vaccine contract, loses 30% of staff
Jul 3, 2024 5:00am
Barinthus lays off 25%, sidelines prostate cancer program
Jun 13, 2024 5:30am
